NEAL C LUMAPAS

Allopathic & Osteopathic Physicians|Internal Medicine DUNNELLON, FL NPI 1013075894

General Payments — all program years on this page

$8,001.83

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 488
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $828.82 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $828.8240

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,745.62118
2019 $1,263.0188
2020 $1,714.02108
2021 $1,286.6773
2022 $367.5720
2023 $796.1241
2024 $828.8240

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086224928 Bayer Healthcare Pharmaceuticals Inc. $24.85 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096647676 Novo Nordisk Inc $24.17 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096896495 Novo Nordisk Inc $17.84 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097244046 Novo Nordisk Inc $22.88 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097381175 Novo Nordisk Inc $14.45 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097391053 Novo Nordisk Inc $16.54 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097511859 Novo Nordisk Inc $25.28 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097577397 Novo Nordisk Inc $17.73 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097672010 Novo Nordisk Inc $22.51 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104275933 AstraZeneca Pharmaceuticals LP $24.59 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104362325 AstraZeneca Pharmaceuticals LP $15.91 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104583904 AstraZeneca Pharmaceuticals LP $28.04 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104662667 AstraZeneca Pharmaceuticals LP $20.86 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104911472 ABBVIE INC. $24.26 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104911474 ABBVIE INC. $30.92 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105485431 AstraZeneca Pharmaceuticals LP $6.85 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105504332 AstraZeneca Pharmaceuticals LP $19.73 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105543807 AstraZeneca Pharmaceuticals LP $16.77 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105582566 AstraZeneca Pharmaceuticals LP $15.08 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105591146 AstraZeneca Pharmaceuticals LP $14.34 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105644518 AstraZeneca Pharmaceuticals LP $19.86 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105732771 AstraZeneca Pharmaceuticals LP $23.37 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105795190 AstraZeneca Pharmaceuticals LP $23.37 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114765224 Exact Sciences Corporation $24.44 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114765229 Exact Sciences Corporation $17.47 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115886099 Amgen Inc. $16.29 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116157323 GlaxoSmithKline, LLC. $18.68 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116602359 GlaxoSmithKline, LLC. $22.35 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116607992 GlaxoSmithKline, LLC. $19.03 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117615237 Amgen Inc. $19.06 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117835298 Boehringer Ingelheim Pharmaceuticals, Inc. $28.57 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129444760 Esperion Therapeutics, Inc. $19.60 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129444762 Esperion Therapeutics, Inc. $21.36 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131048193 PFIZER INC. $23.37 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135176115 Lilly USA, LLC $14.29 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139279764 Astellas Pharma US Inc $29.77 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139280930 Astellas Pharma US Inc $17.16 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139405917 Astellas Pharma US Inc $20.55 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143267835 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.78 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143267839 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.85 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.